Cargando…
Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
The link between Epstein–Barr virus (EBV) and multiple sclerosis (MS) has puzzled researchers since it was first discovered over 40 years ago. Until that point, EBV was primarily viewed as a cancer‐causing agent, but the culmination of evidence now shows that EBV has a pivotal role in development of...
Autores principales: | Thomas, Olivia G, Rickinson, Alan, Palendira, Umaimainthan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191779/ https://www.ncbi.nlm.nih.gov/pubmed/37206956 http://dx.doi.org/10.1002/cti2.1451 |
Ejemplares similares
-
Epstein–Barr virus and multiple sclerosis: the dawn of a new age
por: Phan, Tri Giang
Publicado: (2023) -
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
por: Smith, Corey, et al.
Publicado: (2023) -
Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials
por: Lanz, Tobias V, et al.
Publicado: (2023) -
From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis
por: Dyer, Zoe, et al.
Publicado: (2023) -
The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities
por: Afrasiabi, Ali, et al.
Publicado: (2023)